S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   382.60 (-1.87%)
AAPL   161.43 (-1.42%)
MSFT   322.73 (-2.05%)
FB   306.84 (-1.14%)
GOOGL   2,836.45 (-0.80%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.44 (+1.69%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   382.60 (-1.87%)
AAPL   161.43 (-1.42%)
MSFT   322.73 (-2.05%)
FB   306.84 (-1.14%)
GOOGL   2,836.45 (-0.80%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.44 (+1.69%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   382.60 (-1.87%)
AAPL   161.43 (-1.42%)
MSFT   322.73 (-2.05%)
FB   306.84 (-1.14%)
GOOGL   2,836.45 (-0.80%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.44 (+1.69%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
S&P 500   4,538.43 (-0.84%)
DOW   34,580.08 (-0.17%)
QQQ   382.60 (-1.87%)
AAPL   161.43 (-1.42%)
MSFT   322.73 (-2.05%)
FB   306.84 (-1.14%)
GOOGL   2,836.45 (-0.80%)
AMZN   3,389.79 (-1.38%)
TSLA   1,014.97 (-6.42%)
NVDA   306.93 (-4.46%)
BABA   111.96 (-8.23%)
NIO   32.15 (-11.19%)
CGC   9.99 (-3.57%)
AMD   144.01 (-4.43%)
GE   92.77 (-2.58%)
MU   81.62 (-1.52%)
T   23.44 (+1.69%)
F   19.14 (-3.67%)
DIS   146.22 (-0.67%)
PFE   54.27 (+2.32%)
AMC   29.01 (-4.19%)
ACB   5.82 (-5.21%)
BA   198.49 (-1.92%)
OTCMKTS:OCPNY

Olympus Stock Forecast, Price & News

$22.02
-0.04 (-0.16%)
(As of 12/2/2021 12:00 AM ET)
Add
Compare
Today's Range
$21.84
$22.04
50-Day Range
$20.60
$23.71
52-Week Range
$18.12
$24.26
Volume
35,907 shs
Average Volume
35,642 shs
Market Capitalization
$28.60 billion
P/E Ratio
N/A
Dividend Yield
0.36%
Beta
0.63
30 days | 90 days | 365 days | Advanced Chart
Receive OCPNY News and Ratings via Email

Sign-up to receive the latest news and ratings for Olympus and its competitors with MarketBeat's FREE daily newsletter.


Olympus logo

About Olympus

Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.

Headlines

Olympus Co. (OTCMKTS:OCPNY) Short Interest Up 72.8% in November
November 30, 2021 |  americanbankingnews.com
Olympus Corp. (OCPNY) Upgraded to Buy: Here's Why
November 16, 2021 |  finance.yahoo.com
Olympus Launches Venture Capital Fund To Strengthen Medtech Leadership
November 13, 2021 |  markets.businessinsider.com
What Wall Street expects from OLYMPUS's earnings
November 10, 2021 |  markets.businessinsider.com
Thai Credit Retail Bank Weighing Bangkok IPO Next Year
November 8, 2021 |  finance.yahoo.com
Here's what Wall Street expects from Olympus's earnings
November 5, 2021 |  markets.businessinsider.com
OLYMPUS earnings preview: what to expect
August 5, 2021 |  markets.businessinsider.com
See More Headlines

Industry, Sector and Symbol

Industry
Structural clay products
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:OCPNY
CIK
N/A
Employees
31,653
Year Founded
1919

Sales & Book Value

Annual Sales
$6.89 billion
Cash Flow
$0.82 per share
Book Value
$2.71 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Outstanding Shares
1,299,294,000
Free Float
N/A
Market Cap
$28.60 billion
Optionable
Not Optionable

Company Calendar

Last Earnings
8/05/2021
Today
12/03/2021
Fiscal Year End
3/31/2022

Social Links


MarketRank

Overall MarketRank

1.39 out of 5 stars

Analyst Opinion: 0.0Community Rank: 4.3Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 1.9 5 -4 -3 -2 -1 -












Olympus (OTCMKTS:OCPNY) Frequently Asked Questions

Is Olympus a buy right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Olympus in the last twelve months. There are currently 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "strong buy" Olympus stock.
View analyst ratings for Olympus
or view top-rated stocks.

How has Olympus' stock been impacted by Coronavirus (COVID-19)?

Olympus' stock was trading at $17.6660 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, OCPNY stock has increased by 24.6% and is now trading at $22.0150.
View which stocks have been most impacted by COVID-19
.

Are investors shorting Olympus?

Olympus saw a increase in short interest in November. As of November 15th, there was short interest totaling 45,100 shares, an increase of 72.8% from the October 31st total of 26,100 shares. Based on an average daily volume of 48,200 shares, the short-interest ratio is presently 0.9 days.
View Olympus' Short Interest
.

How were Olympus' earnings last quarter?

Olympus Co. (OTCMKTS:OCPNY) announced its quarterly earnings data on Thursday, August, 5th. The company reported $0.13 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.10 by $0.03. The firm had revenue of $1.75 billion for the quarter, compared to the consensus estimate of $1.49 billion.
View Olympus' earnings history
.

Is Olympus a good dividend stock?

Olympus pays an annual dividend of $0.08 per share and currently has a dividend yield of 0.36%.

Who are Olympus' key executives?

Olympus' management team includes the following people:
  • Yasuo Takeuchi, President, Chief Executive Officer & Director
  • Nacho Abia, Chief Operating Officer
  • Chikashi Takeda, Chief Financial Officer
  • Akihiro Taguchi, Chief Technology Officer
  • Masahito Kitamura, Chief Information Security Officer

What is Olympus' stock symbol?

Olympus trades on the OTCMKTS under the ticker symbol "OCPNY."

How do I buy shares of Olympus?

Shares of OCPNY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Olympus' stock price today?

One share of OCPNY stock can currently be purchased for approximately $22.02.

How much money does Olympus make?

Olympus has a market capitalization of $28.60 billion and generates $6.89 billion in revenue each year.

How many employees does Olympus have?

Olympus employs 31,653 workers across the globe.

Does Olympus have any subsidiaries?

The following companies are subsidiares of Olympus: AVS Co Ltd, Aizu Olympus Co Ltd, Algram Group Ltd, Aomori Olympus Co Ltd, Arc Medical Design Limited, Image Stream Medical Inc, Nagano Olympus Co Ltd, Olympus (Beijing) Sales & Service Co Ltd, Olympus (China) Co Ltd, Olympus (GuangZhou) Industrial Co Ltd, Olympus (Malaysia) Sdn Bhd, Olympus (Thailand) Co Ltd, Olympus America Inc, Olympus America de Mexico SA de CV, Olympus Australia Pty Ltd, Olympus Austria Gesellschaft mbH, Olympus Belgium SA/NV, Olympus Canada Inc, Olympus Corporation of Asia Pacific Limited, Olympus Corporation of the Americas, Olympus Czech Group sro, Olympus Danmark A/S, Olympus Deutschland GmbH, Olympus Digital System Design Corp, Olympus Estonia Oü, Olympus Europa SE & Co KG, Olympus Finland OY, Olympus France SAS, Olympus Hong Kong and China Limited, Olympus Iberia SAU, Olympus Ireland, Olympus Italia SRL, Olympus Korea Co Ltd, Olympus Latin America Inc, Olympus Logitex Co Ltd, Olympus MEA FZ-LLC, Olympus Medical Science Sales Corp, Olympus Medical Systems Corp, Olympus Medical Systems India Private Limited, Olympus Medical Systems Vietnam Co Ltd, Olympus Memory Works Corp, Olympus Moscow Limited Liability Company, Olympus NDT Canada Inc, Olympus Nederland BV, Olympus New Zealand Limited, Olympus Norge A/S, Olympus Optical do Brasil Ltda, Olympus Polska sp zoo, Olympus Schweiz AG, Olympus Scientific Solutions Americas Corp, Olympus Scientific Solutions Technologies Inc, Olympus Singapore Pte Ltd, Olympus Soft Imaging Solutions GmbH, Olympus Surgical Technologies America Inc, Olympus Surgical Technologies Europe (Olympus Winter & Ibe GmbH), Olympus Sverige AB, Olympus Systems Corporation, Olympus Taiwan Co Ltd, Olympus Terumo Biomaterials Corp, Olympus Trading (Shanghai) Limited, Olympus UK & Ireland, Olympus Vietnam Co Ltd, Olympus doo Beograd, Olympus-RMS Corp, Olympus-Supportmate Corp, Shirakawa Olympus Co Ltd, Sony Olympus Medical Solutions Inc, Tecnologias Opticas e Digitais Lda, and TmediX Corporation.

When was Olympus founded?

Olympus was founded in 1919.

What is Olympus' official website?

The official website for Olympus is www.olympus-global.com.

Where are Olympus' headquarters?

How can I contact Olympus?

Olympus' mailing address is SHINJUKU MONOLITH 3-1 NISHI-SHINJUKU 2-CHOME, TOKYO M0, 163-0914. The company can be reached via phone at (133) 340-2111, via email at [email protected], or via fax at 813-3340-2062.


This page was last updated on 12/3/2021 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.